Hormones & Bone Health Unit: pg/mL

Intact Parathyroid Hormone (iPTH)

iPTH regulates calcium and phosphorus balance. In kidney disease, parathyroid glands produce excessive PTH to compensate for failing mineral clearance, leading to renal bone disease.

Standard Normal Range pg/mL
15 - 65 pg/mL in healthy individuals; CKD target ranges vary by stage

Reference ranges can vary slightly between clinical laboratories. Single readings should always be evaluated alongside your overall health history and repeat testing.

What Does Intact Parathyroid Hormone (iPTH) Measure?

Parathyroid hormone (PTH) is made by four tiny glands behind the thyroid in your neck. Its primary physiological job is maintaining constant calcium levels in the blood. When blood calcium drops or blood phosphorus rises, these glands secrete intact PTH, which tells bones to release calcium, instructs the intestines to absorb more calcium, and commands the kidneys to excrete phosphorus and activate vitamin D.

In chronic kidney disease, two things happen: failing kidneys cannot activate vitamin D, causing blood calcium to drop; and kidneys cannot excrete excess phosphorus. Both triggers force the parathyroid glands into overdrive, causing secondary hyperparathyroidism. If left untreated, chronic high PTH leaches minerals directly out of your bones, making them fragile and brittle while depositing calcium into your blood vessels and heart valves.

Reference Ranges & Interpretation

Patient Group / Category Value Range Status Clinical Meaning
Healthy Adults (Normal Baseline) 15 - 65 pg/mL (1.6 - 6.9 pmol/L) Normal Standard physiological range for individuals with normal kidney function.
CKD Stage 3-4 Target Range Normal to 2x Upper Limit (up to ~130 pg/mL) Target CKD Range Slight elevations are an adaptive response. Guidelines advise avoiding abrupt suppression.
CKD Stage 5 / Dialysis Target Range 2 to 9x Upper Limit (~130 - 600 pg/mL) Dialysis Target KDIGO target range for end-stage renal disease to prevent adynamic bone disease.
Severe Hyperparathyroidism Greater than 600 pg/mL High / High Risk Markedly accelerated bone loss, bone pain, and vascular calcification. Requires active medical management.

What Causes High Parathyroid Hormone (iPTH) Levels?

An elevated result does not always mean permanent kidney disease. Clinicians evaluate both kidney-specific conditions and non-kidney factors:

Kidney-Related Cause

Secondary Hyperparathyroidism of CKD

Phosphate retention and impaired renal production of calcitriol (active vitamin D) trigger parathyroid hyperplasia.

Non-Kidney / Lifestyle Factor

Vitamin D Deficiency

Low blood levels of 25-hydroxy vitamin D starve the body of calcium, prompting continuous PTH release.

Non-Kidney / Lifestyle Factor

High Dietary Phosphorus Intake

Excess inorganic phosphate additives in processed foods stimulate parathyroid secretion.

Non-Kidney / Lifestyle Factor

Primary Hyperparathyroidism (Adenoma)

A benign tumor on one of the parathyroid glands autonomous overproduces hormone regardless of kidney function.

What Causes Low Parathyroid Hormone (iPTH) Levels?

Kidney-Related Cause

Adynamic Bone Disease (Overtreatment)

Excessive use of active vitamin D or calcimimetics shuts down parathyroid glands, freezing bone turnover.

Physiological / Dietary Factor

Hypoparathyroidism

Accidental surgical removal or damage to the parathyroid glands during neck or thyroid surgery.

Physiological / Dietary Factor

Severe Hypercalcemia

High circulating blood calcium suppresses parathyroid hormone secretion via feedback loops.

What This Means for Kidney Health

Unlike other lab tests where you want values strictly in the normal lab range, in moderate to advanced CKD (especially dialysis), nephrologists deliberately aim for an iPTH level two to nine times the normal upper limit. If PTH is driven down to completely normal levels in dialysis patients, bones stop remodeling entirely, leading to brittle 'frozen' bone matrix (adynamic bone disease). Treatment involves balancing phosphate binders, nutritional vitamin D, active calcitriol, and calcimimetic drugs like cinacalcet.

Questions to Ask Your Doctor

Bring these practical, clinically focused questions to your next appointment to discuss your Parathyroid Hormone (iPTH) results:

  • Discussion Point: What is my specific target iPTH range for my stage of kidney disease?
  • Discussion Point: How do my calcium, phosphorus, and vitamin D levels interact with my current PTH number?
  • Discussion Point: Would a phosphate binder or an active vitamin D analogue help bring my PTH into a safer target zone?
  • Discussion Point: Are we checking my bone mineral density or monitoring for signs of renal osteodystrophy?

Frequently Asked Questions

Why does high parathyroid hormone hurt my bones in kidney disease?

Because when your blood calcium drops and phosphorus rises, your parathyroid glands treat it as an emergency and steal calcium straight out of your bones to keep blood levels steady. Over months and years, this continuous leaching creates weak, porous bones that break easily.

What are calcimimetics?

Calcimimetics (such as cinacalcet) are medications that mimic calcium on the surface of parathyroid glands. They trick the glands into thinking there is plenty of calcium in the blood, which stops them from overproducing parathyroid hormone.

Authoritative Clinical Guidelines & References

  • KDIGO 2024 Clinical Practice Guideline for Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
  • National Kidney Foundation (NKF) KDOQI Bone Metabolism Guidelines
  • Journal of the American Society of Nephrology: Managing Secondary Hyperparathyroidism
Clinical Disclaimer: This guide provides educational information grounded in published nephrology guidelines. It does not provide medical diagnosis or replace personalized consultation with your nephrologist or physician.